Oracle, Cleveland Clinic, and G42 Announce Strategic Partnership to Launch AI-Based Global Healthcare Delivery Platform

In This Article:

Partnership will build a global AI-powered healthcare platform to deliver more effective, scalable, and affordable care

ABU DHABI, United Arab Emirates, May 16, 2025 /PRNewswire/ -- Oracle Health, Cleveland Clinic, and G42 today announced a strategic partnership to develop a groundbreaking AI-based healthcare delivery platform. This initiative aims to improve patient care and public health management by leveraging AI, nation-scale data analytics, and intelligent clinical applications to create secure, scalable, and accessible care models that positively impact people's health and longevity.

Oracle, Cleveland Clinic, and G42 Announce Strategic Partnership to Launch AI-Based Global Healthcare Delivery Platform
Oracle, Cleveland Clinic, and G42 Announce Strategic Partnership to Launch AI-Based Global Healthcare Delivery Platform

The platform will serve as the foundation for an AI-driven healthcare hub, combining Oracle Cloud Infrastructure, Oracle AI Data Platform, and Oracle Health applications, Cleveland Clinic's world-class clinical expertise, and G42's capabilities in sovereign AI infrastructure, health data integration, and advanced clinical AI models. Designed to meet the evolving needs of global populations, starting with the U.S. and the United Arab Emirates, the platform will deliver secure, scalable, and intelligent healthcare solutions that enhance patient outcomes, enable precision medicine, and support the transition from reactive treatment to proactive wellbeing.

Powering the hospital of the future
Fully AI-enabled health systems will continually analyze population and public health data in real-time, providing practitioners with clinical intelligence at the point of care. Clinicians and public health administrators will also gain deeper insights into the well-being of patient populations at scale and the factors that may be contributing to disease progression and poor outcomes. The platform will also enable organizations to simultaneously improve care quality while driving down costs by finally giving both clinical and operational executives the data, analyses, and predictive capabilities they need to improve patient and financial outcomes.

In tandem, the collaboration will help drive a new era of life sciences innovation by removing the silos between clinical research and clinical care. Providers will be able to more easily identify clinical trial candidates and enroll them in appropriate studies at the point of care. Researchers will be able to access invaluable real-world data to detect opportunities for therapeutic intervention and closely monitor the performance and effects of existing and new therapies to limit risk, support patient safety, and get life-saving new treatments to market faster.

The platform will:

  • Deliver an AI-driven healthcare infrastructure rooted in data privacy, clinical quality, and operational efficiency.

  • Establish a scalable and cost-effective care model that positions the U.S. and UAE as co-leaders in supporting next-generation healthcare solutions.

  • Use AI to enhance diagnostics, personalize treatments, optimize outcomes, and reduce costs at scale.

  • Deliver high-quality, affordable care worldwide, addressing the rising pressures of aging populations and chronic diseases.